ALK fusions have been identified in a variety of neoplasms, including inflammatory myofibroblastic tumor, many subtypes of lymphomas and leukemias, adenocarcinomas, benign fibrous histiocytoma, and several other tumors. Here, ALK is linked to inflammatory myofibroblastic tumor.